Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab.

MLA

Galimberti, S., et al. “Quantitative Molecular Evaluation in Autotransplant Programs for Follicular Lymphoma: Efficacy of in Vivo Purging by Rituximab.” Bone Marrow Transplantation, vol. 32, no. 1, July 2003, p. 57. EBSCOhost, https://doi.org/10.1038/sj.bmt.1704102.

APA

Galimberti, S., Guerrini, F., Morabito, F., Palumbo, G. A., Di Raimondo, F., Papineschi, F., Caracciolo, F., Fazzi, R., Cervetti, G., Cuzzocrea, A., & Petrini, M. (2003). Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab. Bone Marrow Transplantation, 32(1), 57. https://doi.org/10.1038/sj.bmt.1704102

Chicago

Galimberti, S, F Guerrini, F Morabito, G A Palumbo, F Di Raimondo, F Papineschi, F Caracciolo, et al. 2003. “Quantitative Molecular Evaluation in Autotransplant Programs for Follicular Lymphoma: Efficacy of in Vivo Purging by Rituximab.” Bone Marrow Transplantation 32 (1): 57. doi:10.1038/sj.bmt.1704102.